Junji Tomiyama

Suggest Changes

Writes About:

Learn More
The benefits of allogeneic hematopoietic cell transplantation (allo-HCT) for patients with acute myelogenous leukemia (AML) in first complete remission (CR1) have mostly been evaluated in younger(More)